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In compiling official mortality statistics, rules for selecting the underlying cause of death have changed twice in the last 20 years in
England. Mortality statistics for most types of cancer were not greatly affected, but there were significant effects on coding for cancers
of colon, liver, breast, prostate, testis and bladder, and for lymphoma and leukaemia.
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Until recently, only one underlying cause of death on death
certificates has been routinely coded and analysed in most
countries including England. By omitting causes of death that
are not coded as the underlying cause, official statistics under-
estimate the extent to which specific diseases, such as specific
cancers, contribute to the mortality of a population.
Interpretation of mortality statistics based only on underlying
cause is also complicated by changes over time in the rules for
selecting the underlying cause. Rules changed in England in 1984
and 1993 with different approaches to applying rule 3 of the
International Classification of Diseases (ICD) (WHO, 1977; OPCS,
1985; Harvey et al, 1991; ONS, 1996). This rule specifies a number
of diseases, including pneumonia, thromboembolism and heart
failure, that should not be coded as the underlying cause of death,
even if certified as such by the certifying doctor, if other diseases
such as cancer are also on the death certificate; instead, rule 3
prescribes that the other disease should be selected as the
underlying cause (WHO, 1977). The rule was rigorously imple-
mented by the Office of National Statistics in England and Wales in
the period 1984–1993 and then partially reversed (OPCS, 1985;
ONS, 1996). In 1993, multiple-cause coding of death certificates
was introduced as standard practice in England, but information
about multiple-cause mortality for longer-term trends is not
available nationally. We have used a regional database that
included all certified causes of death from 1979 to 1999, not just
those selected as the underlying cause, with the aim of comparing
underlying- and multiple-cause-coded rates for cancers.
METHODS
The former Oxford National Health Service Region covered a total
population of about 2.5 million people. All causes of death on each
death certificate in this population were coded for the years 1979–
1999, for the Oxford record linkage study (Goldacre et al, 2000),
using the 9th ICD revision codes. In each year, the underlying
cause of death was selected and coded according to the prevailing
national rules. Following convention, all certified causes of death –
underlying cause plus causes elsewhere on the certificate – are
termed ‘mentions’.
The database was searched for records with mentions of
malignant neoplasms (ICD codes 140–208). We analysed the data
in three time periods defined by changes to coding rules, 1979–
1983, 1984–1992 and 1993–1999, to calculate the percentage of
mentions that were coded as the underlying cause of death in each
period. We tested changes in these percentages between time
periods by w
2 tests on the numbers on which the percentages were
based. We then calculated changes over time in annual mortality
rates, standardised by applying the age-specific rates in the Oxford
region population in each year to the European standard
population. We calculated the average annual percentage change
over time in mortality rates for mentions by fitting linear
regression models to the logarithms of the death rates. We
calculated changes in rates for mentions using every individual
year. We calculated rates for underlying cause using individual
years before and after the rule 3 changes, that is, omitting data for
1984–1992. We omitted these years to determine whether, if the
discontinuity in the application of the rule was ignored, trends in
mentions and underlying cause were similar.
RESULTS
Table 1 shows the extent to which underlying cause statistics
underestimate the total mortality ascribed to cancers. For example,
in 1993–1999 mortality from all cancer was 10% higher, and that
from breast cancer was 21% higher, than that judged from data on
underlying cause alone.
Comparing periods with different coding rules (Table 1), the
ratio of mentions to underlying cause showed statistically
significant and noteworthy differences for cancer of the colon,
liver, breast, prostate, testis, bladder, Hodgkin’s disease, non-
Hodgkin’s lymphoma, lymphoid and myeloid leukaemia (we
defined noteworthy as a significant change in the ratio of more
than 5%). Statistically significant, but numerically smaller, changes
in the ratios between the periods with different coding rules were
seen for cancers of the oesophagus, pancreas and lung. Changes in
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yTable 1 Mention-based mortality rates per 100000 population; ratio of death with a mention of each cancer to death certificates with the cancer as the
underlying cause of death; and average annual change in mortality rates with 95% confidence interval (95% CI in italics)
Ratio of mentions to underlying cause
Cancer site or type (ICD
codes; N¼number of
deaths with mentions)
Mention-based
mortality rates
per 100000
1979–1999 1979–1983 1984–1992 1993–1999
Average annual % change in
mortality rates and 95% CI:
mentions, 1979–1999
Average annual % change in
mortality rates and 95% CI:
underlying cause 1979–1999
excluding 1984–1992
All cancer (140–208;
N¼128068)
228.7 1.11 1.07
*** 1.10
***  0.8  0.9  0.6  0.7  0.9  0.6
Tongue (141; N¼365) 0.7 1.24 1.17 1.20  0.1  2.1 1.9 0.1  1.9 2.2
Salivary glands (142; N¼176) 0.3 1.07 1.08 1.19  0.2  2.9 2.5  1.6  4.2 1.2
Nasopharynx (147; N¼127) 0.2 1.07 1.10 1.19  3.3  5.7  0.8  4.0  7.3  0.5
Oesophagus (150; N¼4499) 7.9 1.09 1.05
*** 1.06 1.6 0.9 2.2 1.7 0.9 2.6
Stomach (151; N¼6858) 12.4 1.08 1.06
*** 1.07
*  4.2  4.6  3.7  4.1  4.5  3.7
Rectum (154; N¼5318) 9.5 1.14 1.12 1.14
*  2.3  2.8  1.7  2.4  2.9  1.9
Colon and rectum (153 154;
N¼15572)
27.0 1.15 1.10
*** 1.13
***  1.4  1.8  1.1  1.4  1.7  1.0
Liver and intrahepatic bile
ducts (155; N¼1256)
2.2 1.23 1.05
*** 1.07 2.5 2.0 3.0 3.5 2.8 4.2
Gallbladder and extrahepatic
bile duct (156; N¼729)
1.2 1.09 1.05 1.10  4.5  5.7  3.3  4.6  5.9  3.3
Pancreas (157; N¼5375) 9.3 1.07 1.03
*** 1.04  0.5  0.9  0.2  0.4  0.8 0.1
Digestive organs and
peritoneum (159; N¼997)
1.5 1.09 1.06 1.13
** 8.1 6.7 9.6 7.9 6.3 9.6
Nasal cavities, middle ear,
access sinuses (160; N¼161)
0.3 1.19 1.05 1.09  5.6  8.6  2.4  4.8  8.6  0.8
Larynx (161; N¼775) 1.5 1.22 1.28 1.44
*  0.6  2.0 0.9  1.7  3.5 0.2
Trachea, bronchus and lung
(162; N¼28021)
53.3 1.06 1.05 1.06
***  2.3  2.6  2.1  2.4  2.6  2.1
Pleura (163; N¼373) 0.7 1.06 1.04 1.02 4.8 3.0 6.6 5.0 3.4 6.7
Bone and articular cartilage
(170; N¼282)
0.5 1.16 1.08 1.05  1.2  3.8 1.5 0.0  2.5 2.6
Connective and other soft
tissue (171; N¼563)
1.0 1.12 1.06 1.09 1.7 0.2 3.2 1.9 0.3 3.5
Malignant melanoma of skin
(172; N¼1268)
2.3 1.09 1.07 1.06 2.3 1.2 3.4 2.7 1.1 4.3
Other cancer of skin (173;
N¼463)
0.8 1.62 1.39 1.56  0.6  2.3 1.1 0.0  1.7 1.8
Female breast (174;
N¼13807)
44.3 1.14 1.10
*** 1.15
***  0.8  1.2  0.5  0.9  1.3  0.4
Uterus, part unspecified (179;
N¼650)
1.9 1.30 1.13
** 1.22
*  1.3  3.5 1.0  0.7  3.2 1.8
Cervix (180; N¼1367) 4.7 1.11 1.09 1.15
*  4.1  5.2  3.0  4.2  5.5  3.0
Body of uterus (182; N¼789) 2.4 1.15 1.16 1.20  2.7  3.9  1.4  3.2  4.5  1.9
Ovary and other uterine
adnexa (183; N¼3503)
12.0 1.05 1.03 1.06
*** 0.3  0.5 1.0 0.2  0.5 0.9
Prostate (185; N¼8732) 35.0 1.39 1.19
*** 1.30
*** 1.5 1.2 1.9 1.9 1.2 2.6
Testis (186; N¼134) 0.5 1.03 1.15 1.72
**  3.6  7.0 0.0  6.5  9.2  3.7
Penis (187; N¼125) 0.5 1.39 1.06
** 1.28
*  3.9  6.6  1.0  3.4  6.2  0.7
Bladder (188; N¼4759) 8.7 1.30 1.21
** 1.26
** 1.0  1.4  0.6  0.9  1.3  0.5
Kidney (189; N¼2338) 4.3 1.18 1.11
** 1.15 1.8 0.9 2.6 1.8 1.0 2.5
Brain (191; N¼2541) 4.9 1.04 1.02
* 1.04
* 0.5  0.2 1.2 0.3  0.3 0.9
Thyroid gland (193; N¼299) 0.5 1.13 1.10 1.15  1.3  3.5 1.0  2.1  3.7  0.5
Lymphosarcoma,
reticulosarcoma (200;
N¼282)
0.5 1.12 1.20 1.19  10.0  12.0  8.0  10.1  12.5  7.5
Non-Hodgkin’s lymphoma
(200+202; N¼3642)
6.4 1.19 1.12
** 1.18
*** 1.7 1.1 2.2 1.6 1.1 2.1
Hodkin’s disease (201;
N¼489)
0.9 1.20 1.20 1.40
*  4.2  6.0  2.4  5.1  6.9  3.3
Other cancer of lymphoid and
histiocystic tissue (202;
N¼3364)
5.9 1.21 1.11
*** 1.18
*** 2.9 2.3 3.5 3.0 2.2 3.7
Multiple myeloma and
immunoproliferative cancers
(203; N¼2292)
4.0 1.20 1.12
** 1.20
*** 0.4  0.3 1.0 0.2  0.7 1.2
Lymphoid leukaemia (204;
N¼1447)
2.5 1.39 1.39 1.56
*  0.6  1.9 0.8  1.5  3.4 0.4
All cancers with more than 400 cases, or with significant changes in ratios or annual rates (cancers coded as those at ill-defined or unspecified sites excluded)
*Po0.05;
**Po0.01;
***Po0.001.
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prostate cancer as an example: between 1979–1983 and 1984–
1992, the ratio of mentions to underlying cause decreased from
1.39 to 1.19, or, in other words, in the later of the two periods a
higher percentage of certificates that included prostate cancer were
coded with prostate cancer as the underlying cause. This meant
that underlying-cause mortality rates for prostate cancer (the only
rates available from routine statistics) exaggerated the rise from
1979–1983 to 1984–1992. The subsequent increase in the ratio of
mentions to underlying cause, from 1.19 in 1984–1992 to 1.30 in
1993–1999, means that a lower percentage of cases with prostate
cancer were coded with the disease as the underlying cause in the
later than in the earlier of these two periods. In this example, the
trends for underlying-cause and mentions converge comparing the
first and second periods, and diverge comparing the second and
third periods (Figure 1).
Age-standardised death rates, expressed as mentions per 100000
resident population, showed a significant increase over time for
cancers of the oesophagus (in men only), liver, malignant
melanoma, prostate, kidney, and non-Hodgkin’s lymphoma.
Significant decreases over time were found for cancers of the lip,
stomach, colon, rectum, gall bladder, pancreas, lung (in men only),
breast, bladder, Hodgkin’s disease and non-Hodgkin’s lymphoma.
Omitting the middle time period, these trends based on underlying
cause were similar to those based on mentions.
DISCUSSION
The ratios of mentions to underlying cause show the extent to
which statistics for underlying cause, alone, have underestimated
the population toll of cancer mortality. For certain cancers, studies
of trends in rates that use underlying cause only, starting or
finishing in years between 1984 and 1992, may be misleading. In
general, however, the impact of the rate changes on cancer was
small. Particularly, if data for the years 1984–1992 are ignored,
rates show similar trends whether analysed for mentions or for
underlying cause. As we have shown, even over a period as short as
two decades, many cancers show significant upward or downward
trends.
Consideration needs to be given to the distinction between
dying with a cancer and dying from a cancer. Particularly for
cancers in which therapy has been successful, the certifying doctor
may consider that the cancer, though appropriate to certify as a
contributing cause, was not the underlying cause of death. As
treatment improves, for some cancers it can be expected that there
will be a trend away from certifying the cancer as the underlying
cause of death in affected people who die. Testicular cancer and
Hodgkin’s lymphoma are examples (Table 1). Trends in mortality
statistics for cancer, based on underlying cause alone, may be
particularly difficult to interpret when the period studied coincides
with changes in practice in the selection of the underlying cause.
CONCLUSION
Multiple-cause coding of mortality in England has become routine
since 1993. In analysing cancer mortality rates, consideration
should be given to rates based on mentions as well as underlying
cause, particularly when the analysis crosses periods of change to
selection rules.
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Figure 1 Mortality rates for cancer of prostate, expressed as age-
standardised rates per million population and as 3-year moving averages
around each calendar year, comparing prostate cancer coded as the
underlying cause of death, and coded as a cause on any part of the death
certificate.
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